Oncolytics Biotech Inc. (ONCY)
ONCY Stock Price Chart
Explore Oncolytics Biotech Inc. interactive price chart. Choose custom timeframes to analyze ONCY price movements and trends.
ONCY Company Profile
Discover essential business fundamentals and corporate details for Oncolytics Biotech Inc. (ONCY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Oct 2001
Employees
28.00
CEO
Wayne F. Pisano
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
ONCY Financial Timeline
Browse a chronological timeline of Oncolytics Biotech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.11.
Earnings released on 8 Aug 2025
EPS came in at -$0.05 surpassing the estimated -$0.11 by +54.55%.
Earnings released on 14 May 2025
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%.
Earnings released on 7 Mar 2025
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%.
Earnings released on 12 Nov 2024
EPS came in at -$0.09 falling short of the estimated -$0.08 by -12.50%.
Earnings released on 1 Aug 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%.
Earnings released on 9 May 2024
EPS came in at -$0.07 surpassing the estimated -$0.09 by +22.22%.
Earnings released on 7 Mar 2024
EPS came in at -$0.04 surpassing the estimated -$0.11 by +63.64%.
Earnings released on 3 Nov 2023
EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%.
Earnings released on 14 Aug 2023
EPS came in at -$0.09 matching the estimated -$0.09.
Earnings released on 5 May 2023
EPS came in at -$0.07 matching the estimated -$0.07.
Earnings released on 3 Mar 2023
EPS came in at -$0.10 falling short of the estimated -$0.05 by -100.00%.
Earnings released on 7 Nov 2022
EPS came in at -$0.06 surpassing the estimated -$0.09 by +33.33%.
Earnings released on 11 Aug 2022
EPS came in at -$0.07 surpassing the estimated -$0.09 by +22.22%.
Earnings released on 5 May 2022
EPS came in at -$0.09 surpassing the estimated -$0.13 by +30.77%.
Earnings released on 3 Mar 2022
EPS came in at -$0.11 surpassing the estimated -$0.14 by +21.43%.
Earnings released on 5 Nov 2021
EPS came in at -$0.07 surpassing the estimated -$0.15 by +53.33%.
Earnings released on 6 Aug 2021
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.
Earnings released on 7 May 2021
EPS came in at -$0.10 surpassing the estimated -$0.17 by +41.18%.
Earnings released on 5 Mar 2021
EPS came in at -$0.16 falling short of the estimated -$0.13 by -23.08%.
Earnings released on 11 Nov 2020
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%.
ONCY Stock Performance
Access detailed ONCY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.